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Abstract: This study considers fundamental methods in occupational risk assessment of 
exposure to airborne engineered nanomaterials. We discuss characterization of particle 
emissions, exposure assessment, hazard assessment with in vitro studies, and risk range 
characterization using calculated inhaled doses and dose-response translated to humans 
from in vitro studies. Here, the methods were utilized to assess workers’ risk range of 
inhalation exposure to nanodiamonds (NDs) during handling and sieving of ND powder. 
NDs were agglomerated to over 500 nm particles, and mean exposure levels of different 
work tasks varied from 0.24 to 4.96 µg·m
−3
 (0.08 to 0.74 cm
−3
). In vitro-experiments 
suggested that ND exposure may cause a risk for activation of inflammatory cascade. 
However, risk range characterization based on in vitro dose-response was not performed 
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because accurate assessment of delivered (settled) dose on the cells was not possible. 
Comparison of ND exposure with common pollutants revealed that ND exposure was 
below 5 μg·m−3, which is one of the proposed exposure limits for diesel particulate matter, 
and the workers’ calculated dose of NDs during the measurement day was 74 ng  
which corresponded to 0.02% of the modeled daily (24 h) dose of submicrometer urban  
air particles. 
Keywords: nanomaterial; occupational hygiene; source characterization; exposure assessment; 
dose assessment; in vitro 
 
1. Introduction 
Industrial use of materials engineered at the nanometer scale has grown rapidly worldwide [1]. 
Nanotechnology has been identified as one of the most promising technologies in advanced societies [2]. 
In Europe alone, the nanotechnology sector is believed to employ 400,000 persons by 2015 [3]. 
However, during the last decade, there has been a growing amount of evidence that some engineered 
nanomaterials (ENMs; see definition by ISO [4]) may be toxic to humans (e.g., [5–7]). 
Exposures to ENMs most readily occur when the materials are produced and handled [5,8].  
For such exposure, inhalation is the most relevant pathway for ENM uptake [9]. Quantitative risk 
assessment and control of ENMs is currently based on ENM exposure assessment and hazard 
assessment with in vivo studies (Figure 1).  
Figure 1. Principal steps of ENM risk assessment: identify particle sources, assess ENM 
hazard and exposure levels, and characterize risk of the ENM exposure. Exposure control 
measures are based on the risk level which can be used to estimate an upper limit on the 
acceptable ENM concentration in workplace air. 
 
Currently, there are no health-based exposure limits or toxicological test guidelines specific for ENMs. 
This is because the use of conventional protocols [10] to derive no-effect levels is challenging to use for 
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particulate matter due to the lack of adequate data. Thus, the risk assessment of exposure to ENMs 
currently relies on hazard assessment based on available toxicological data [11]. 
Risk assessment of airborne ENMs (Figure 1) begins with identifying particle emitters [12],  
where size resolved ENM concentrations are discriminated from background particles [13–15],  
and the ENM exposure levels are used to calculate inhaled doses [15,16]. The ENM hazards are 
assessed with in vivo experiments for specific toxicological endpoints [17,18] and translated to the 
human equivalent dose-response [10,19]. Such risk assessment has been suggested for workers 
exposed to TiO2 nanoparticles [20–23] and carbon black particles during material production [21]. 
However, some of these risk assessment models have been criticized mainly due to inappropriate 
dose–response assessment and exposure data [24–26]. 
The scientific and regulatory communities are currently discussing ways to develop faster and  
more predictive tools for assessing ENM hazards such as using in vitro experiments [27–30].  
Snyder-Talkington et al. [31] used in vitro studies to evaluate hazards of multi-walled carbon 
nanotubes which were linked via mouse equivalent dose to the human equivalent dose. They postulated 
that a 10 μg dose given to a mouse represents a (nominal) concentration of less than 1 μg·mL−1 in vitro 
corresponding to a human equivalent inhalation dose where a worker is exposed to an aerosol 
concentration of 400 μg·m−3 for one month. Recently Hinderliter et al. [32] developed an in vitro cell 
dosimetry model that may be used to accurately estimate the delivered (settled) dose onto cells if 
proper ENM dispersion protocol is used [33]. 
This study considers the risk assessment of inhalation exposure to ENMs (Figure 1), applied to 
workers handling Molto
®
 nanodiamond (ND) powder (see material data sheet by vendor in 
Supplementary Information Figure S1 and Mochalin et al. [34] for ND synthesis, properties, and use). 
Measured particle size distributions were used to discriminate the ND concentrations from background 
particles and ND emission rates were characterized during handling, sieving, and cleaning of NDs. 
Work task based mean ND exposure levels were used to calculate workers inhaled dose rates.  
The cytotoxicity of NDs was studied in the THP-1 cell line by assessing cell death and ability to 
produce reactive oxygen species (ROS) and IL-1β, IL-8, and TNF-α cytokines. Assessment of the  
in vitro dose-deposited on cells was not considered reliable, due to the fact that the model did not take 
into account ND agglomeration in dispersion, and thus risk range characterization was not performed.  
The ND exposure and dose levels were compared with one of the proposed exposure limits for diesel 
particulate matter and with the inhaled dose of urban particulate matter exposure. 
2. Experimental Section 
2.1. Work Environment 
The workplace was located in a sub-urban area in a modern office building. The incoming 
ventilation air was filtered with a EU7 grade filter (HGFS-F7-592/892/600-8-25, Camfil Farr, 
Stockholm, Sweden), and during working hours, the ventilation rate was set to approximately 2 h
−1
.  
In the laboratory, daytime relative humidity and temperature were, on average, 20% and 23 °C, 
respectively. During work tasks, the laboratory doors were closed and the room was at a 6 Pa under 
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pressure compared to the corridor (Figure 2). ND sieving was performed with the vibratory sieve 
shaker (Retsch AS 300, Retsch Technology GmbH, Haan, Germany). 
Figure 2. Layout of the work area. Light red shows the ND handling area during work tasks. 
 
Figure 2 shows the layout of the laboratory, location of the instruments, and area where NDs were 
handed. There were three work tasks: (a) ND handling in a glove box and sieving in a fume chamber 
(WT1); (b) ND handling in a under pressurized glove box and sieving in a room (WT2);  
and (c) cleaning operations (WT3). During the work day, 2 kilograms of ND powder was handled.  
In the glove box, ND bags were opened, weighed and poured on the sieve. The closed sieve containing 
NDs from 200 to 500 grams was transported to the sieve by hands where it was opened and attached to 
the vibratory shaker. Duration of the sieving varied from a few minutes to ten minutes. In cleaning 
operations, surfaces were wiped with wet tissues, components were washed in a washing chamber,  
and empty ND bags were disposed of into special waste bins. During the work tasks, workers wore 
face piece respirators (Willson 5321 FFP3D, W1005602, Bacou-Dalloz USA, Smithfield, RI, USA) of 
which the nominal protection factors were 200 (European standard EN529 [35]), cotton clothing,  
nitrile gloves, and sleeve protectors. 
2.2. Aerosol Measurements 
The particle number concentration was measured from a workstation with a condensation particle 
counter (CPC, Qs = 0.70 L·min
−1
, TSI Model 3007, TSI Inc., Shoreview, NM, USA).  
Measurement size range was approximately from 10 nm to over 1 µm with a time resolution of 1 s. 
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The breathing zone concentration was measured with a Miniature Diffusion Size Classifier 
(DISCmini, Qs = 0.96 L·min
−1
, sampling through 1 m with inner diameter of 4 mm conductive rubber 
tube without a cyclone or pre-impactor and the inlet located approximately 15 cm from the worker 
mouth). DISCmini is a diffusion charger that measures the current carried by the aerosol particles [36,37]. 
The current is proportional to particle diameter from Dp
1
 to Dp
2
, which is referring to the active surface 
area of particulate matter [38–40]. The measurement size range was approximately from 20 to ~700 nm 
and the instrument time resolution was 1 s. 
The work station air and incoming ventilation air particle concentrations were measured with  
a scanning mobility particle sizer (SMPS), which consisted of a classifier (TSI Classifier model 3080) 
and a 10 μCi 85Kr neutralizer, TSI model 3077A), a HAUKE-type differential mobility analyzer 
(DMA, length 28 cm, inner diameter 2.5 cm and outer diameter 3.3 cm, sheath air flow 6.0 L·min
−1
, 
and a condensation particle counter (CPC, TSI model 3776, Qs = 1.43 L·min
−1
). The SMPS scan time 
was 45 s with a 15 s retrace time. The aerosol was sampled with a 3-way valve altering between the 
work station (length 1.2 m, tube inner diameter 4 mm) and the incoming ventilation air dispenser 
(length 4 m, tube inner diameter 4 mm). Both sampling lines were flushed with flows of 3.6 L min
−1
 to 
decrease the sample residence time. Diffusion losses of the sampling lines were corrected according to 
Baron and Willeke [41]. The measurement size range of the SMPS was from 14.1 nm to 572.5 nm. 
An optical particle counter (OPC, Qs = 1.18 L·min
−1
, and the instrument default settings were: 
refractive index 1.59 + 0i, density 2.6 g·cm
−3
, and spherical particle assumption, Model 1.109,  
Grimm Aerosoltechnik, Ainring, Germany) measured work station optical particle mass size 
distributions from 234.5 nm to 31 μm with a time resolution of 60 s. These particle mass size 
distributions were transformed to particle number and mass distributions for which the density was 
assumed to be 1 g·cm
−3
 for particles below 500 nm in diameter and 0.5 g·cm
−1
 for particles over  
500 nm in diameter. This corresponds to the ND powder bulk density (see Supplementary Information)  
and roughly the effective density of atmospheric particles in urban area with a size greater than 500 nm 
in diameter [42]. 
The OPC size distributions were averaged to two minute samples that corresponded to the SMPS 
work station measurement time interval. Then, the work station size distributions measured by the 
SMPS and OPC were combined by removing the OPC size fractions smaller than 289.2 nm  
(lower boundary 278.4 nm) and the SMPS size fractions of over 278.8 nm. The SMPS largest size bin 
was cut 0.4 nm so that the upper boundary limit was the same as the OPC smallest size bin lower 
boundary limit of 278.4 nm. For the SMPS cut size bin was calculated new geometric mean size d50, 
bin concentration dN, and logarithmic width of the bin dLog(Dp). Thus, the combined size distribution 
named here as SMPS + OPC, was continuous and ranged from 14.1 nm to 31 μm consisting of  
111 size classes. Here it was assumed that a particle’s mobility diameter and optical diameter were 
equivalent even though optical diameter may differ significantly from mobility diameter depending on  
the particles refractive index and shape [43,44]. 
Particle aerodynamic size distributions were measured from the work station with an electrical  
low-pressure impactor with a filter stage (ELPI, Qs = 9.6 L·min
−1
, Dekati Ltd., Tampere, Finland). 
Measurement time resolution was 1 s, which was averaged for data analysis to  
60 s. The measurement size range was 7 nm to 10 µm (13 size classes), and in the data inversion,  
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the density was assumed to be 1 g cm
−3
. Room temperature and relative humidity were measured with 
a TR-73U logger (Thermo, T&D Corporation, Nagano, Japan). 
The instruments were placed on a measurement trolley where the inlets were at a height from  
1.2 to 1.4 m facing towards the work area (Figure 2). Measurements were taken over three consecutive  
days where the first and last days were used to set up the instrumentation and for non-working  
hour concentration measurements. The actual work was performed during the second day  
between 9:31 and 15:23. 
2.3. Electron Microscopy 
Electron microscope samples were collected with a Nanoguard (IUTA/TSI) electrostatic precipitator 
pre-prototype on Si substrate and onto holey carbon film-coated copper grids of 200-mesh  
(SPI, West Chester, PA, USA) to air sample cassettes (inlet diameter 1/8 inch and filter diameter 25 mm,  
SKC Inc., 863 Valley View Road Eighty Four, PA, USA) on polycarbonate filter. Samplers located at 
the measurement trolley. Si substrate was imaged by using an UltraPLUS FEG-SEM  
(Zeiss, Oberkochen, Germany) and INCA Energy 350 EDS-system (Oxford Instruments 
NanoAnalysis, High Wycombe Bucks, England) and grids by using a transmission electron microscope 
(TEM, JEM 1220, Jeol, Tokyo, Japan). 
2.4. Dynamics of Nano-diamonds: Emissions and Settling 
The dynamic behavior of aerosol particles can be described by the general mass-balance equation [12]. 
Here, it was applied to describe the mass concentration change, dM/dt (µg·s
−1
·m
−3
), at the work  
station as: 
  inindout
in SMMP
dt
dM
   (1)  
where M (µg·m
−3
) is the mass concentration with in and out referring to the indoor and outdoor 
concentration respectively, P (unitless) is the penetration factor of aerosols while being transported 
from the outdoor into the indoor air, λ (h−1) is the ventilation rate, λd (h
−1
) is the deposition rate of 
aerosols, and Sin (µg·s
−1
·m
−3
) is the source rate of producing aerosols indoors (mass-based). 
Assuming that the indoor aerosol particles are produced with significantly large amounts so that the 
term Sin is much larger than other two terms on the right hand side, then the source strength can be 
easily calculated as: 
inin M
dt
d
S   (2)  
When the process emission stops, mass concentration decay to the background concentration level 
after a time period that depends on the ventilation rate and the deposition rate; i.e., the deposition rate 
of aerosols right after the source was terminated, can be estimated as: 
 
 









ttM
tM
t in
in
d ln
1
  (3)  
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where Δt is the time interval for the indoor aerosol mass concentration to decay at the background 
concentration level. 
2.5. Calculation of Regional Inhalation Dose 
The regional inhalation dose rate (min
−1
) was calculated by multiplying size fractioned concentrations 
by the respiratory minute volume (L·min
−1
) and the regional deposition probabilities while air is 
inspired and expired. In this model, we used the human respiratory tract deposition probability model 
as determined by the International Commission on Radiological Protection [45].  
Deposition probabilities are defined as a function of aerodynamic diameter, which is linked to a 
mobility diameter with an effective density [46]. In this study, we assumed that particle densities 
would be 1 g·cm
−3
 for particles below 500 nm in diameter and 0.5 g·cm
−1
 for particles over 500 nm in 
diameter. For the lung deposition calculation over 500 nm particles size was converted to aerodynamic 
equivalent diameter according to Hinds [47] where particles dynamic shape factor was set to 1.37.  
This is typical value for compact agglomerates for which the dynamic shape factor varies usually  
from 1.3 to 1.4 [48]. Particle growth during inspiration and expiration was assumed to be negligible 
and workstation concentrations were assumed to correspond to the workers exposure concentrations. 
The workers’ respiratory minute volume was assumed to be 25 L·min−1, which corresponds to male 
respiration during light exercise. The regional deposition probabilities were calculated by using simplified 
regional deposition probabilities during nasal breathing for the head airways, the tracheobronchial 
region, and the alveolar region [49].  
2.6. In vitro-experiments 
2.6.1. Cell Culture 
The human monocytic leukaemia cell line THP-1 was obtained from the American Type Culture 
Collection (cat. TIB-202, ATCC, Rockville, MD, USA) and maintained in RPMI 1640 cell culture 
medium (Invitrogen, Paisley, UK) supplemented with 1% L-glutamine (Ultraglutamine
®
; Lonza, 
Basel, Switzerland), 10% fetal bovine serum (FBS, Gibco by Life Technologies, Paisley, UK), 1% 
HEPES (Lonza), 1% penicillin-streptomycin (PEST; Invitrogen), 1% non-essential amino acids 
(Lonza)  
and 0.05 mM 2-mercaptoethanol (Lonza). In order to induce monocyte-to-macrophage differentiation, 
the THP-1 cells were cultured for 48 h in the standard culture medium supplemented with 100 nM 
phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, Schnelldoff, Germany). The cells were seeded 
into 12-well plates (Multiwell™ TC Plates, Cat. No. 35304, BD Biosciences Discovery Labware, 
Franklin Lakes, NJ, USA) at a density of 5 × 10
5
/well to study cell death and cytokine secretion and 
into 24-well plates (Wallac Visiplate, Visiplate-24, PerkinElmer, Zaventem, Belgium) at a density of  
3 × 10
5
/well to study ROS generating ability.  
2.6.2. Dispersion Preparation 
Dispersions of Molto
®
 ND for the in vitro experiments were made up by weighing NDs into glass 
tubes and preparing a 1,000 μg·mL−1 stock dispersion in phosphate buffered saline (dPBS) which was 
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sonicated for 20 min at 30 °C. The stock solution was further serially diluted to form different final 
nominal concentrations in RPMI 1640 cell culture media with supplemental 1% PEST and  
1% L-glutamine (LDH and ELISA assays) or Dulbecco’s phosphate-buffered saline (dPBS without 
CaCl2/MgCl2, Gibco by Life Technologies; ROS generating ability) and sonicated for 20 min at 30 °C 
just before cell exposures. Old media was carefully removed and the cells were exposed to different 
doses of NDs for 3 h (ROS generating ability) or 6 h (LDH, ELISA assays). 
2.6.3. Analysis of Cell Death and Cytokine Secretion 
The ability of Molto
®
 ND to evoke cell death was investigated via the release of lactase 
dehydrogenase enzyme (LDH) into the cell culture medium, by the cytotoxicity detection kitPLUS 
(Roche, Mannheim, Germany) according to manufacturer’s instructions. The ND nominal 
concentrations used in the cytotoxicity tests were 1, 10, 100 and 500 μg·mL−1. The secretion of  
pro-inflammatory cytokines IL-1β, TNFα and IL-8 was studied by commercial enzyme-linked 
immunosorbent (ELISA) assays after the THP-1 cells had been exposed to NDs at 10 and 100 μg·mL−1. 
All ELISA assays were purchased from eBiosciences (San Diego, CA, USA), and performed 
according to the manufacturer’s instructions. Bacterial lipopolysaccharide Escherichia coli serotype 
O111:B4 (LPS, Sigma-Aldrich) was used as a positive control because of its known ability to activate 
the secretion of pro-inflammatory cytokines from macrophages. Two independent repeats of the 
experiments were performed. 
2.6.4. Determination of ROS Generating Ability 
The effect of Molto
®
 ND on ROS generation was assessed both with THP-1 cells and in the  
cell-free environment. 2',7'-Dichlorofluorescein diacetate (DCFH-DA, Calbiochem, Darmstadt, 
Germany) was used to detect intracellular ROS production. After DCFH-DA has crossed cell 
membrane, it is de-esterified to a non-fluorescent 2',7'-dichloridihydrofluorescein (DCFH) which is 
unable to pass back through cell membranes and therefore it cannot leave the cells. DCFH can be 
oxidised to the intracellular, fluorescent 2',7'-dichlorofluorescein (DFC) by reactive oxygen species, 
such as hydroxyl radicals, peroxynitrite, and nitric oxide [50,51]. In the cell free environment,  
DCFH-DA can be chemically hydrolysed to DCFH by treatment with 0.01 M NaOH for 30 min,  
after which the test material is added and its ROS producing capability is determined [50].  
THP-1 cells were seeded into 24-well plates (Wallac Visiplate, Perkin Elmer) and differentiated 
into macrophages as described above. The DCFH-DA solution was diluted into dPBS, THP-1 cells 
were washed twice with dPBS, and DCFH-DA was added to the cells at 0.01 mM final concentration. 
After 1 h, the cells were washed once with dPBS and exposed for 3 h to 10, 100 and 500 μg·mL-1 ND 
dispersions prepared as described above. Three independent repeats of the cell experiments were 
performed. In addition, parallel experiments using DCFH were performed in the cell-free environment 
with appropriate unlabelled controls being included. DFC was determined at λex 490 and λem 520 nm on 
a fluorescence spectrophotometer (Victor Wallac-2 1420, Perkin Elmer). H2O2 (500 mM) was used as 
a positive control. The results are given as intracellular H2O2 concentrations (nM) calculated with the 
following equation: H2O2 (nM) = 0.0004 × fluorescence-86. 
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3. Results 
Figures 3a,b show the particle concentration time series measured during the work day between 
8:30–16:30. The work station air concentration measured by the SMPS+OPC before and after the work 
day between 16:30–8:30 were on average 4,600 ± 2,900 particles cm−3 and 3.05 ± 1.27 μg·m−3  
(± refers to one standard deviation). 
The average background concentrations were defined before and after work tasks as follows:  
(a) background concentration 1 (BG1) measured from the work station air between 9:11–9:21 and 
11:44–11:54; and (b) background concentration 2 (BG2) measured from the work station air between 
12:28–12:38 and 15:30–15:40 (Figure 3a). BG1 and BG2 were defined separately for each instrument. 
The work task concentrations were averaged over the measurement period for each instrument as 
follows: WT1 09:21–11:44, WT2 12:38–14:35, and WT3 14:36–15:23 (Figure 3a). The WT2 and 
WT3 concentrations had the same background concentration (BG2). Mass distribution averages for the 
background’s and work task’s concentrations are shown in Figure 4. 
Electron microscopy analysis showed that the work station airborne particles consisted of inorganic 
carbon (data not shown), which originated from outdoor combustion sources, agglomerated NDs, and 
other particles whose composition was not defined (Figure 5). 
Figure 3. Concentration time series during the work day: (a) shows the particle and mass 
concentrations; (b) shows the particle size distributions measured with the SMPS + OPC 
and the average particle size defined by the DISCmini. The horizontal blue lines and the 
horizontal black lines in (a) show the start and end time for background concentrations 
(BG1 and BG2) and work tasks (WT1, WT2, and WT3), respectively. The vertical solid 
and dashed thin black lines show the start and end times of the work tasks. 
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Figure 4. Mass distribution averages for the background’s (BG1 and BG2) and work task’s 
(WT1, WT2, and WT3) concentrations calculated from the SMPS + OPC measurements. 
 
Figure 5. Scanning (left) and transmission (right) electron micrographs of particles 
sampled from the work station air. 
 
3.1. Exposure Assessment 
The Appendix shows that the most reliable metrics to characterize ND exposure levels was mass 
concentration derived from the SMPS + OPS measurements. Mass emission rates of ND agglomerates 
were estimated for six major mass concentration peaks shown in Figure 3a. In the emission rate 
modelings, ND agglomerates were estimated to have a mean diameter of 5 μm. The deposition rate 
was found to vary from 0.8 to 1.9 h
−1
. The variation was most likely caused by incomplete air mixing 
and air mass movement caused by the workers’. The maximum ND emission rates for WT1, WT2, 
and WT3 were respectively 6.1, 12.4, and 2.2 μg·min−1·m−3, while particles were emitted to the work 
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station air at a rate of 4.3 μg·min−1·m−3 when ND emissions were excluded (Table 1). It must be noted 
that Equation (1) assumes particles fully mixed in air which may not be valid in this case.  
Thus the emission rate term was expressed as (units·min
−1
·m
−3
). The air mixing without workers can 
be estimated with computational fluid dynamics. 
Figure 3a shows that the breathing zone concentration measured by the DISKmini and work station 
mass concentration peaks occurred approximately at the same time. This supports the assumption that 
the work station air concentrations and the exposure levels were similar. The work tasks’ mean ND 
particle number and mass size distributions were calculated by subtracting BG1 from WT1 and BG2 
from WT2 and WT3 (Figure 4), and excluding particles below 500 nm in diameter.  
These concentrations were used to calculate work task based ND dose rates and doses where workers’ 
use of the respirators with nominal protection factor of 200 was taken into account (Table 1). 
Table 1. ND exposures, emission rates for mass peak concentrations during work tasks, 
and calculated dose rates, and doses of ND agglomerates to the head-airways (H-A), 
trachea-bronchiolar (TB), and alveolar regions. The exposure concentration was defined 
from the SMPS + OPC particle size distributions where particles smaller than 500 nm in 
diameter were removed. Mass concentration was calculated by assuming that the particles 
effective density was 0.5 g·cm
−3
. The dose was calculated over the time period of  
respective work task. 
Unit WT1 WT2 WT3 
ND exposure a 0.08 cm−3 0.24 μg m−3 0.74 cm−3 4.96 μg·m−3 0.30 cm−3 1.54 μg·m−3 
ND emission rate 6.1 μg·min−1·m−3 1.7 to 12.4 μg·min−1·m−3 2.2 μg·min−1·m−3 
Dose rate b 2.2 min−1 0.03 ng·min−1 26.0 min−1 0.53 ng·min−1 8.8 min−1 0.16 ng·min−1 
Dose c 310 4 ng 3,100 62 ng 410 8 ng 
H-A, (%) 59 87 66 88 62 90 
TB, (%) 5 5 6 5 5 4 
Alveolar, (%) 36 8 28 7 33 6 
Notes: a ND concentration in workstation air; b,c The use by workers of respiratory protection with a nominal 
protection factor of 200 was taken into account. 
3.2. Assessment of NDs Toxicity in vitro 
In order to study the mass based dose-response of NDs on cells, THP-1 cells were exposed to 1, 10, 
100 and 500 μg·mL−1 ND dispersions. The ND agglomerates growth in the dispersion prevented to use 
the in vitro dosimetry model [32] to calculate the dose delivered on the THP-1 cells.  
The ND dispersion characteristics, in vitro dose-responses, and dose translation from in vitro to 
humans is presented in Supplementary Information, but the results were not used in this study. 
Cytotoxicity depended on ND nominal concentration as seen in Figure 6a. The NDs showed a clear 
capability to trigger ROS production in the cell-free environment. The intracellular production of ROS 
was lower, although it depended on the nominal mass concentration of ND particles (Figure 6b).  
The levels of secreted IL-1β protein were increased dose-dependently, whereas there were no changes 
in TNF-α and IL-8 protein secretion compared to untreated cells (Figures 6c–e). The results suggest 
that exposure to nano-sized ND evoked biological responses in the exposed cells. 
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Figure 6. Nanodiamond Molto particles induce pro-inflammatory response. (a) Cell death 
of macrophages induced by 1, 10, 100 and 500 μg/mL of NDs; (b) PBS, H2O2 positive 
control with cells, Acellular (open bars), and cellular (filled bars) ROS production induced 
by 10, 100 and 500 μg/mL of NDs; (c) IL-1β; (d) IL-8 and (e) TNF-α cytokine secretion 
from macrophages induced by 10 and 100 μg/mL of NDs. Error bars represent ±SD of two 
(a, c–e) or three (b) independent experiments. 
 
4. Discussion 
NDs agglomerated to over 500 nm particles and their levels in terms of number and surface area 
concentration was low as compared to background levels (see Appendix). Mass units were used for the 
ND exposure assessment because of reliability (see Appendix) and because a toxicologically relevant 
metric is not defined for ND agglomerates. It must be noted that single ND agglomerate carries 
millions of primary ND particles 5–6 nm in diameter (Figure 2, Supplementary Information Figure S1) 
which may be dispersed when deposited on the respiratory fluid. Choi et al. [52] showed that 
nanoparticles with dH < 34 nm translocate rapidly from the lungs to lymph nodes. From lymph nodes, 
nanoparticles with dH < 6 nm moved to the bloodstream and extrapulmonary organs. Exposure to 
urban air nano-sized particles has been found to induce health effects such as cardiovascular [53] and 
central nervous diseases [54]. 
Even though the ND agglomerates are mainly deposited in the head airways, it was calculated  
that 7% of them penetrated to the alveolar region. In alveoli, macrophages are the first cells to 
encounter the particles as they act as the first-line of defense cells and engulf invading particles [55]. 
They also orchestrate the inflammatory response by secreting cytokines and chemokines, which recruit 
other inflammatory cells into the lungs. This cross-talk between different cell types is an important part 
of the pro-inflammatory response and macrophages represent the first step to trigger the activation 
cascade of the inflammatory response [31]. 
Nanodiamond Molto
®
 showed relatively low cytotoxicity, a marked production of ROS,  
and a dose-dependent secretion of the pro-inflammatory cytokine, IL-1β, in THP-1 cells.  
The production of intracellular ROS has been shown to be associated with the secretion of IL-1β via 
NLRP3-inflammasome activation orchestrating the activation of the pro-inflammatory cascade in cells 
exposed to cholesterol or silica crystals, crocidolite asbestos or rigid carbon nanotubes [56–58]. 
Activation of this pathway has been suggested to be an important tool for separating hazardous  
nano-sized fibers from their non-hazardous counterparts [58]. With spherical shaped ENM,  
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the suitability of NLRP3 inflammasome activation studies to the hazard identification process is still 
unclear. Thus the role of the NLRP3 inflammasome in fiber and particle induced inflammation has to 
be further studied in the future. 
To estimate the dose delivered (settled) on the cells with the in vitro dosimetry model by  
Hiderliter et al. [32], a stable dispersion where particles are distributed in a narrow size region 
(monodisperse distribution) is needed. Cohen et al. [33] presented a protocol for the production of 
stable monodisperse dispersions for in vitro studies. However, this may not mimic workers’ exposure 
to ENM powders where agglomerates are distributed into a wide size range, as seen here or as shown 
for example by Koivisto et al. [16]. Breaking the agglomerates for in vitro studies may also change the 
toxicological outcome as shown by Haniu et al. [59], who observed a decrease in toxicity when 
agglomerate size was decreased, obviously due to reduced exposure of the cells. 
Demokritu et al. [60] made a direct comparison between in vitro and in vivo studies  
with physiologically equivalent doses and found that in vitro studies may not predict well  
toxicological outcomes in vivo. On the other hand, Khatri et al. [61] successfully linked in vitro 
experiments with human volunteers [62] and experimental animal [63] inhalation studies.  
This encourages developing in vitro studies so that the preliminary hazard assessment could be made 
for specific toxicological end points and for certain ENMs, as discussed more detailed in  
the Supplementary Information. 
4.1. Comparison of ND Exposure with Provisional Exposure Limit Values for Nanoparticles and 
Diesel Particulate Matter 
There are provisional exposure limit values for ENMs, called nano reference values (NRVs),  
which are designed to provide warning concentration levels for ENMs, to judge when exposure control 
measures should be taken [64,65]. The NRVs are designed for ENM particles in the range of 1–100 nm 
and thus cannot be utilized here, because the NDs had agglomerated into particles approximately  
over 500 nm. Thus, other limit values need to be considered in order to estimate the need for risk 
control measures. 
For diesel particulate matter, 5 μg·m−3 is one of the proposed exposure limits to which humans may 
be exposed throughout their lifetime without experiencing any adverse noncancer health effects [66].  
If one assumes that NDs and diesel particulate matter are similar in terms of toxicity, then this may be 
used to estimate an exposure limit when control measures are needed. ND concentrations were the 
highest (4.96 μg·m−3) during WT2. This suggests that risk control measures should be taken if sieving 
is performed extensively in a room. However, if the sieving is performed inside the fume chamber,  
as during WT1, ND exposure is reduced approximately to 5% of WT2 ND exposure (Table 1). 
The ND emission rates may be used to estimate the increase in ND concentration level if the work 
is scaled-up and if the work station environmental conditions remain similar [67] and in risk 
assessment tools, such as, Stoffenmanager Nano [68]. 
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4.2. Comparison of a Work Day ND Dose with a Daily Dose of Submicrometer Urban  
Background Particles 
Here the daily dose of ND agglomerates was compared with the daily dose of submicron urban 
background particles where exposures to local sources have been excluded. For an office worker with 
a typical activity pattern and who is living and working in a similar area where the workplace was 
located in this study, such modeled dose would be approximately 38 μg per work day [69].  
The workers’ calculated dose of NDs during the measurement day was 74 ng which is approximately 
500 times smaller than the daily dose of submicrometer urban background particles.  
Recently, the International Agency for Research on Cancer (IARC) classified diesel engine exhaust 
particles [70] and outdoor air pollution [71] as carcinogenic to humans (Group 1). NDs have not been 
classified for carcinogenicity but they have been assumed to be less toxic than other carbon  
particles [72,73]. This may be because diesel engine exhaust particles contain mutagenic and 
carcinogenic chemicals [66] which do not exist in NDs [34]. 
5. Conclusions 
Risk assessment of inhalation exposure to airborne engineered nanomaterials is currently challenging 
due to lack of occupational exposure limits for ENMs. Here assessment of risk range was performed to 
nanodiamond (ND) inhalation exposure in a laboratory environment. 
In in vitro studies, NDs showed low cytotoxicity, a clear production of ROS and a dose-dependent 
secretion of the pro-inflammatory cytokine, IL-1β, in THP-1 cells in THP-1 cells. Results suggested 
that ND exposure may cause a risk for activation of inflammatory cascade. The assessment of in vitro 
delivered dose on the cells was not reliable because the model used did not take into account ND 
agglomeration in the cell culture dispersion, and thus, risk range characterization based on in vitro 
dose-response was only discussed. 
Because NDs were agglomerated to over 500 nm particles, mass concentration was the only reliable 
metric to discriminate the ND concentrations from background particles. During ND handling, sieving, 
and cleaning, ND exposure levels varied from 0.24 to 4.96 µg·m
−3
 (0.08 to 0.74 cm
−3
) while the work 
station air background concentration varied from 4.28 to 4.25 µg·m
−3
 (13 × 10
3
 to 5.9 × 10
3
 cm
−3
), 
respectively. Calculated dose of NDs during the work day was 0.02% of the average daily (24 h) dose 
of submicrometer urban background particles. The ND exposure levels were below 5 μg·m−3,  
which is one of the proposed exposure limits for diesel particulate matter. 
Our results show that ND exposure levels were low, but ND hazard assessment was not sufficient  
in this study considering risk characterization and control. NDs short and long term health effects and 
translocation potential to other organs should be studied with in vivo methods. We recommend 
performing sieving in a fume chamber, which reduced exposure to 5% as compared with sieving 
without the cabinet, and use of respirators if there is potential exposure to high ND concentrations. 
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Appendix 
Metrics to Characterize ND Concentrations 
Averaged work task and the work station air background concentration ratios were used to identify 
the metrics that were sensitive to the ND concentrations compared to background concentrations 
(Table A1). A value less than 1 indicated that there was a particle sink, whereas a value over 1 was an 
indication of particle emissions. Because no significant particle sinks related to the work activity were 
identified (such as, for example, air cleaners or significant changes in coagulation sink),  
the values below 1 indicated uncertainties in determining the background concentration. This could be 
caused by fluctuations in incoming ventilation air concentration, unknown indoor sources or sinks,  
or changes in instrument response while measuring the concentrations. Here the incoming ventilation 
air particle number concentration (Figure 3a) and active surface area concentration (data not shown) 
varied markedly which explained the below 1 concentration ratios respective units. 
Table A1. Concentration ratios for WT1, WT2, and WT3 defined from particle number, 
current, and mass concentrations. 
Metric Ratio Instrument WT1/BG1 WT2/BG2 WT3/BG2 
Number ratio 
SMPS a 0.90 0.93 0.92 
SMPS + OPC 1.11 1.16 0.87 
ELPI 1.11 1.14 0.83 
CPC 1.18 1.16 0.80 
DISCmini 0.85 1.22 0.93 
Current ratio 
DISCmini b 0.914 1.10 0.92 
ELPI c 1.02 1.17 0.96 
Mass ratio 
ELPI 1.14 1.32 0.62 
SMPS + OPC 1.04 2.29 1.41 
Notes: a Background defined from incoming ventilation air measured over the corresponding work task;  
b Total current, i.e., the sum of diffusion stage and filter stage currents; c The sum of currents measured by 
the electrometres from the impactor stages. 
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The incoming ventilation air total number concentration measured by the SMPS was approximately 
8% higher than the work station number concentration (Figure 3a, Table A1). This means that work 
station total particle number concentration was derived by outdoor particles entering via ventilation 
inlets. The particle number concentration ratios shown in Table A1 revealed that ND concentrations 
could not be easily distinguished from the background particles if one used only the number 
concentration (designated by particle diameter Dp.). During WT2, the DISCmini number concentration 
ratio was elevated to 1.22, suggesting that ND exposure did occur. Figure 3b shows that the DISCmini 
predicted well the average particle size when there were no particles approximately over 1 μm present. 
The ND concentrations did not increase the current levels (designated by particle diameter from  
Dp
1
 to Dp
2
) significantly during the work tasks (Table A1). Thus, their active surface area 
concentration was low as compared to the active surface area of the background particles. 
During WT2 and WT3, the mass concentration ratios (designated by particle diameter Dp
3
)  
derived from the SMPS + OPC measurements were elevated to 2.29 and 1.41, respectively.  
The ELPI mass concentration ratios were considered unreliable (Table A1). This was most likely  
due to the low concentration of large particles in general and thus the signal to noise ratio of  
the electrometers was high. 
Figure 4 shows that during the work tasks over 500 nm particle concentrations were leveled up 
which caused peaks in mass concentration (Figure 3b). These peaks were linked to individual work 
events (event times are not shown here), such as assembling the sieve or transport of NDs from glove 
box to the vibratory sieve shaker. Examination of electron micrographs revealed that these particles 
were agglomerated NDs (Figure 5). Sensitivity tests showed that the limit of 500 nm for the smallest 
size of ND agglomerates was very sensitive during the ND exposure in terms of number concentration 
but was negligible on mass concentration. For example, if the smallest size of NDs had been increased 
to 800 nm, this would have decreased mass concentration by 0.3%. Thus, the ND emissions from the 
processes affected mainly mass concentration but their contribution to total number concentration was 
insignificant (Figure 3a, Table A1); the most reliable metrics to characterize ND concentrations was 
mass (or volume) concentration. 
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